Danish drugmaker Novo Nordisk is set to launch its popular diabetes drug Ozempic in India this month. This move aims to capture a significant share of India's growing weight-loss treatment market. Ozempic, known for its effectiveness in managing type 2 diabetes and aiding weight loss, will soon be available.

See Full Page